Epidemiology, characteristics, treatments, and outcomes of adult-onset Still's disease in Afro-Caribbeans: Results from a population-based study in Martinique, French West Indies.

[1]  P. Quartier,et al.  Systemic juvenile idiopathic arthritis in French Afro-Caribbean children, a retrospective cohort study , 2022, Pediatric Rheumatology.

[2]  C. Deligny,et al.  Good Long-Term Prognosis of Lupus Nephritis in the High-Income Afro-Caribbean Population of Martinique with Free Access to Healthcare , 2022, Journal of clinical medicine.

[3]  A. Iagnocco,et al.  Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease , 2022, Rheumatology.

[4]  T. Hosoya,et al.  Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still’s disease , 2021, Arthritis Research & Therapy.

[5]  J. Pouchot,et al.  Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis , 2021, Arthritis Research & Therapy.

[6]  Qing Wu,et al.  Prevalence Trend and Disparities in Rheumatoid Arthritis among US Adults, 2005–2018 , 2021, Journal of clinical medicine.

[7]  B. Fautrel,et al.  Clinical Phenotypes of Adult-Onset Still’s Disease: New Insights from Pathophysiology and Literature Findings , 2021, Journal of clinical medicine.

[8]  A. Aouba,et al.  Cardiac involvement in adult-onset Still's disease: Manifestations, treatments and outcomes in a retrospective study of 28 patients. , 2020, Journal of autoimmunity.

[9]  F. Atzeni,et al.  Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients , 2020, Arthritis Research & Therapy.

[10]  G. Guggino,et al.  Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study , 2019, Medicine.

[11]  A. Jawad,et al.  The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus , 2016, Rheumatology.

[12]  M. Valenti,et al.  Adult-onset Still’s disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers , 2016, BMC Medicine.

[13]  T. Henry,et al.  Treatment of adult-onset Still’s disease: a review , 2014, Therapeutics and clinical risk management.

[14]  I. Touitou,et al.  Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions. , 2014, Autoimmunity reviews.

[15]  P. Sève,et al.  Adult-onset Still's disease. , 2014, Autoimmunity reviews.

[16]  A. López-Guillermo,et al.  Adult haemophagocytic syndrome , 2014, The Lancet.

[17]  D. Maucort-Boulch,et al.  Adult-Onset Still Disease , 2014, Medicine.

[18]  Chengde Yang,et al.  Clinical Features and Prognosis of Adult-onset Still’s Disease: 61 Cases from China , 2009, The Journal of Rheumatology.

[19]  H. Nossent,et al.  Epidemiology and outcome of adult‐onset Still's disease in Northern Norway , 2006, Scandinavian journal of rheumatology.

[20]  J. Piette,et al.  Proposal for a New Set of Classification Criteria for Adult-Onset Still Disease , 2002, Medicine.

[21]  M. Akizuki,et al.  Preliminary criteria for classification of adult Still's disease. , 1992, The Journal of rheumatology.

[22]  J. Esdaile,et al.  Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients , 1991, Medicine.

[23]  L. Cooperstein,et al.  Adult-onset Still's disease. Clinical course and outcome. , 1987, Arthritis and rheumatism.

[24]  OUP accepted manuscript , 2022, Rheumatology.

[25]  A. Tamakoshi,et al.  Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan. , 1997, Journal of epidemiology.